Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations

Overview of attention for article published in Therapeutics and Clinical Risk Management, March 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 68 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 38 publications that cite this research output.

38

The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.

Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein–Protein Interaction Inhibitors

Article in Journal of Medicinal Chemistry (February 2024)

Identification of novel Nrf2-activating neuroprotective agents: Elucidation of structural congeners of (-)-galiellalactone and congener-based novel Nrf2 activators

Article in Bioorganic Chemistry (January 2024)

Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis

Article in Brain Research (November 2023)